Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    CORNEAL DYSTROPHY, CONGENITAL STROMAL
Show Display Options
Rank Status Study
1 Not yet recruiting Immunosuppression During Penetrating Keratoplasty, Using a Subconjunctival Implant Releasing Dexamethasone : Tolerance and Safety Pilot Study
Conditions: Keratoconus;   Fuchs' Endothelial Dystrophy;   Congenital Hereditary Stromal Dystrophy of the Cornea
Intervention: Drug: Dexamethasone implant OZURDEX

Indicates status has not been verified in more than two years